PATENT CLAIM ANALYSIS

Application Number: 15765082
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "649000"]

Abstract:
Methods of treating cancer include administering a therapeutically effective amount of a pharmaceutical composition containing a pharmaceutically acceptable carrier and a compound that is a GPR55 antagonist to a subject having a tumor including cancer cells that have developed a resistance to one or more chemotherapeutic agents. In embodiments, the compound is a fenoterol analogue, such as for example, MNF.

Claim (Index 12):
The method of  claim 1  the pharmaceutical composition results in increased cytotoxicity of one or more chemotherapeutic agents with respect to the cancer cells of a tumor.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 90.0
- Lexical Diversity: 1.35417
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15225643', '15273147', '12810457', '15126777', '15430123']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7807065225495484
- 35 USC 102 Novelty (BERT): 0.5519426253278713
- Combined Prediction Score: 0.7578301328273808
- Mean Citation Score: 286.826548
- Max Citation Score: 427.44946
- Similarity Product: 297.60749183148863

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test